Abstract
Objective To analyze the effect of Maixuekang Capsule on the treatment outcome of coronary heart disease (CHD) by propensity score. Methods Based on the electronic medical record database of 22 large-scale tertiary hospitals nationwide, this study matched the coronary heart disease patients using and not using Maixuekang capsule according to a certain standard (1∶1). After matching, there were 2 464 cases in the patients group (group A) and the patients group (group B). In the database, the recombination of recovery and improvement is defined as effective treatment, and invalid , death and other are combined as ineffective treatment population. The effectiveness of the two groups after the re combination is compared by propensity score. Results The results of χ2 test showed that the difference between the two groups was statistically significant (P 0, and there was statistical significance (P<0.01). Conclusions The therapeutic effect of Maixuekang capsule on coronary heart disease is higher than that of patients without the drug. Key words: Propensity score; Maixuekang capsule; Coronary disease; Electronic health records
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
